Thermo Fisher Scientific Inc. (TMO)

Growth

Revenue 5Y16.69%
Revenue 3Y21.52%
EPS 5Y25.77%
EPS 3Y24.26%
Dividend 5Y14.11%
Dividend 3Y16.06%

Capital Efficiency

ROIC10.47%
ROE16.27%
ROA7.14%
ROTA8.70%

Capital Structure

Market Cap230.25B
EV256.21B
Cash8.52B
Current Ratio1.48
Debt/Equity0.55
Net Debt/EBITDA2.38
Show More

Ratios

Select a metric from the list below to chart it

Dec '94
Dec '00
Dec '06
Dec '12
Dec '18
Ratios
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Price to Book Ratio
2.4
2.5
2.6
3.3
3.6
4.3
5.8
5.5
5.0
5.2
Price to Book Ratio % Chg.
-1.3%
1.6%
6.5%
27.0%
7.1%
20.7%
35.7%
-5.5%
-9.1%
3.7%
Price to Earnings Ratio
26.3
26.7
28.0
38.1
33.5
34.6
31.7
29.2
31.8
33.0
Price to Earnings Ratio % Chg.
-19.1%
1.3%
5.0%
36.2%
-12.0%
3.2%
-8.5%
-7.9%
9.1%
3.7%
Price to Free Cash Flow Ratio
22.7
22.0
20.9
24.2
26.0
31.6
29.6
33.2
32.0
41.0
Price to Free Cash Flow Ratio % Chg.
-5.1%
-3.3%
-5.2%
16.2%
7.4%
21.5%
-6.3%
12.1%
-3.6%
28.0%
Price to Operating Cash Flow Ratio
19.0
18.7
17.9
21.2
21.7
25.7
24.4
24.2
24.2
28.2
Price to Operating Cash Flow Ratio % Chg.
-7.6%
-1.8%
-4.1%
18.1%
2.4%
18.6%
-5.4%
-0.6%
-0.2%
16.9%
Price Earnings to Growth Ratio
0.8
6.3
8.7
3.8
1.1
1.3
0.4
1.3
-3.3
-3.5
Price Earnings to Growth Ratio % Chg.
-79.2%
739.8%
36.7%
-56.7%
-69.8%
15.8%
-67.4%
211.4%
-
4.6%
Price to Sales Ratio
3.0
3.1
3.1
4.1
4.0
5.0
6.3
5.7
4.9
5.1
Price to Sales Ratio % Chg.
-6.7%
5.1%
-0.3%
30.9%
-0.2%
23.9%
25.1%
-8.3%
-14.3%
3.7%
EV to EBITDA
14.8
16.0
17.0
20.7
18.6
20.4
21.1
21.4
21.0
23.4
EV to EBITDA % Chg.
-17.1%
8.1%
6.3%
21.3%
-9.9%
9.6%
3.4%
1.3%
-1.7%
11.4%